TerrAscend “announced that on June 23, 2023, it closed the first tranche of its previously announced concurrent private placements for total gross proceeds of approximately $16 million. Additionally, the Company upsized the offering to $20 million. A second tranche closing is scheduled for June 28, 2023. The closing of the initial tranche of the Private Placements consists of an aggregate of 4,071,577 units (the “Units”) of the Company (the “Equity Offering”) at a price of US $1.50 per Unit (the “Issue Price”) for aggregate gross proceeds of approximately US $6.1 million and 9,905 senior unsecured convertible debentures (the “Debentures”) of the Company (the “Debenture Offering”) at a price of US $1,000 per Debenture for aggregate gross proceeds of US $9.9 million. The net proceeds from the Private Placements will be used to qualify for the Company’s proposed TSX listing, to fund Maryland dispensary acquisitions, and for working capital and general corporate purposes.”
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TRSSF:
- TerrAscend Upsizes Previously Announced Offering to US $20 Million and Closes US $16 Million Initial Tranche
- TerrAscend Announces Results of Annual General and Special Meeting of Shareholders
- TerrAscend Receives Conditional Approval to List on the TSX
- TerrAscend Announces Proposed US $15 Million Private Placements
- TerrAscend Receives Regulatory Approval for Acquisition of Peninsula Alternative Health